Microbot Medical Statistics
Share Statistics
Microbot Medical has 16.93M shares outstanding. The number of shares has increased by 40.98% in one year.
| Shares Outstanding | 16.93M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 3.37% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 16.55M |
| Failed to Deliver (FTD) Shares | 87 |
| FTD / Avg. Volume | 0.05% |
Short Selling Information
The latest short interest is 565.98K, so 3.34% of the outstanding shares have been sold short.
| Short Interest | 565.98K |
| Short % of Shares Out | 3.34% |
| Short % of Float | 3.42% |
| Short Ratio (days to cover) | 2.65 |
Valuation Ratios
The PE ratio is -1.56 and the forward PE ratio is -1.94.
| PE Ratio | -1.56 |
| Forward PE | -1.94 |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 3.72 |
| P/FCF Ratio | -1.95 |
| PEG Ratio | n/a |
Enterprise Valuation
Microbot Medical Inc. has an Enterprise Value (EV) of -.
| EV / Earnings | null |
| EV / Sales | null |
| EV / EBITDA | null |
| EV / EBIT | null |
| EV / FCF | null |
Financial Position
The company has a current ratio of 2.09, with a Debt / Equity ratio of 0.
| Current Ratio | 2.09 |
| Quick Ratio | 2.09 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -2.39% and return on capital (ROIC) is -208.26%.
| Return on Equity (ROE) | -2.39% |
| Return on Assets (ROA) | -1.29% |
| Return on Capital (ROIC) | -208.26% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -511.43K |
| Employee Count | 21 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -22.9% in the last 52 weeks. The beta is 1.63, so Microbot Medical 's price volatility has been higher than the market average.
| Beta | 1.63 |
| 52-Week Price Change | -22.9% |
| 50-Day Moving Average | 0.97 |
| 200-Day Moving Average | 1.01 |
| Relative Strength Index (RSI) | 53.48 |
| Average Volume (20 Days) | 177.75K |
Income Statement
In the last 12 months, Microbot Medical had revenue of $0 and earned -$10.74M in profits. Earnings per share was $-1.05.
| Revenue | 0 |
| Gross Profit | -106.00K |
| Operating Income | -9.86M |
| Net Income | -10.74M |
| EBITDA | -10.63M |
| EBIT | - |
| Earnings Per Share (EPS) | -1.05 |
Balance Sheet
The company has $2.47M in cash and $231.00K in debt, giving a net cash position of $2.24M.
| Cash & Cash Equivalents | 2.47M |
| Total Debt | 231.00K |
| Net Cash | 2.24M |
| Retained Earnings | -79.50M |
| Total Assets | 5.21M |
| Working Capital | 3.62M |
Cash Flow
In the last 12 months, operating cash flow was -$8.53M and capital expenditures -$33.00K, giving a free cash flow of -$8.57M.
| Operating Cash Flow | -8.53M |
| Capital Expenditures | -33.00K |
| Free Cash Flow | -8.57M |
| FCF Per Share | -0.84 |
Margins
Gross margin is 0%, with operating and profit margins of 0% and 0%.
| Gross Margin | 0% |
| Operating Margin | 0% |
| Pretax Margin | 0% |
| Profit Margin | 0% |
| EBITDA Margin | n/a% |
| EBIT Margin | n/a% |
| FCF Margin | n/a% |
Dividends & Yields
MBOT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -103.96% |
| FCF Yield | -50.31% |
Analyst Forecast
The average price target for MBOT is $7, which is 593.1% higher than the current price. The consensus rating is "Buy".
| Price Target | $7 |
| Price Target Difference | 593.1% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Sep 5, 2018. It was a backward split with a ratio of 1:15.
| Last Split Date | Sep 5, 2018 |
| Split Type | backward |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | -21.92 |
| Piotroski F-Score | 2 |